🔗 Share this article

Given that the United States proceeds with sweeping revisions to its immunization schedules, an unexpected name has emerged in a surprising turn: Tracy Beth Høeg, a Danish American sports medicine doctor and public health researcher who initially gained attention by expressing skepticism about COVID-19 shots throughout the global health crisis and has zeroed in on possible fatalities following Covid vaccination in her brief tenure at the FDA.

Planned Changes to Childhood Vaccine Program

Agency leaders had intended to announce major revisions to the childhood vaccine schedule recently, aligning the US with the Danish immunization schedule, it is understood – a significant shift that would place the US out of step with much of the world with no evidence for benefit. This reveal has been delayed until the next year.

In place of the director of the vaccine center, Tracy Beth Høeg is listed to present at the gathering. She was recently named interim head of the FDA’s drug evaluation center, the fifth person to lead the office this calendar year.

Consolidating Power at the Regulatory Body

This interim role might represent a closer partnership between the pharmaceutical and biologics divisions as Høeg and Dr. Prasad solidify control at the FDA – and it points to a renewed priority upon rolling back long-standing vaccines at the FDA.

Dr. Høeg has repeatedly called for ending certain pediatric vaccine recommendations in the US so as to align more like Denmark's approach, a society with universal health coverage and a population approximately the population of Wisconsin’s.

To date comments, she has kept her attention on immunizations – typically the responsibility of Prasad, head of the FDA’s CBER – as opposed to medication approval.

Concerns Over Qualifications

Høeg has little discernible experience in drug development, regulation or administrative roles, which has been standard for past leaders of the biologics center. She has served at the FDA as a top consultant to the agency head and CBER since March.

“She appears not to have the requisite experience” for running the pharmaceutical oversight division, remarked Jonathan Howard. “She’s never run a scientific study. She lacks experience in running a sizeable institution. She is not an expert in pharmaceutical oversight.”

Former commissioners of the center would “grasp legal statutes and the underlying principles of medication creation”, commented Dr. Janet Woodcock. “Clearly, she doesn’t have the type of experience that former directors who ran the center have had.”

The drug center has an immense portfolio at the FDA, she emphasized.

“The public just focuses on the innovative therapies, but the generic drug division approves thousands of generic medications. There is also a biologic copycat branch, over-the-counter program and other areas, and all of those need to be managed,” Dr. Woodcock explained. “The responsibility you neglect, that is the part that I always told people is going to come back to haunt you.”

Furthermore, a significant leadership aspect to the job, which manages more than 5,000 staff members. “It is a enormous management job, if you execute it properly,” Woodcock added.

Official Statement and Controversial Policies

When asked about concerns about Dr. Høeg's credentials and whether this assignment represents increased cooperation among regulatory chiefs on vaccines, a press secretary stated that the “questions are based on inaccurate presumptions”.

“Her resume is consistent with the functions of her job,” the spokesperson explained, noting the months Høeg spent advising the FDA commissioner on “pharmaceutical safety and oversight research, including computational safety modeling and immunization monitoring”.

As the temporary head, Høeg assumes responsibility for the agency head's recently launched expedited review system, a controversial one-day drug-approval program that allegedly troubled her predecessors. “How are these therapies being selected for this voucher program? Who makes the choices?” Howard said. “There is a lot of lack of transparency going on at the agency right now.”

Overall, he remarked, “the Food and Drug Administration appears to be shifting towards laxer oversight of pharmaceuticals, with the exception of shots.”

Documented History on Vaccines

Concerning vaccines, Dr. Høeg has a more established, if concerning, track record, some experts have noted. She authored a research paper using unverified volunteer-provided data to assess the rate of myocarditis following COVID-19 immunization. She advised the state of Florida top health official Dr. Joseph Ladapo, who was said to have changed statistics to suggest COVID-19 vaccinations are more dangerous than they are.

Among her “wish list” for the incoming administration featured changing rules for recently developed shots and halting “unnecessary” immunizations, she said after the election on a online show. At the FDA, Høeg has according to sources proposed excluding adolescent males from receiving Covid vaccinations.

“She’s an complete true believer who begins with her beliefs and tailors the evidence to retrofit the data in a highly deceptive, untruthful way,” Howard argued.

Taking Control and a “Revenge Tour”

Høeg joined fellow skeptics, {like|